Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Olivia Fu, MD
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-1232) Dose selection of obeldesivir for clinical evaluation in treatment of adult participants with respiratory syncytial virus infection
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET